Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 965-972

  Zhang, Yong ^a   Yang, Chao Qun ^b   Gao, Yang ^b   Wang, C E ^b   Zhang, Cheng Lin ^b   Zhou, Xu Hui ^b  

^a Zhabei District Central Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CXCR7; Growth; Invasion; Osteosarcoma

Indexed keywords

BETA ARRESTIN; CHEMOKINE RECEPTOR CXCR7; CYCLINE; GELATINASE B; LENTIVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; CHEMOKINE RECEPTOR CXCR; CXCR7 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MG 63 CELL LINE; NONHUMAN; OSTEOSARCOMA CELL; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR VOLUME; TUMOR XENOGRAFT; U2OS CELL LINE; WESTERN BLOTTING; ANIMAL; BONE NEOPLASMS; CELL MOTION; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENETICS; METABOLISM; MOUSE; OSTEOSARCOMA; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; HUMANS; MALE; MICE; NEOPLASMS, EXPERIMENTAL; OSTEOSARCOMA; RECEPTORS, CXCR; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84907885805     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3290     Document Type: Article

References (32)

1. Chen X, Luther G, Zhang W, et al: The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem 32: 1083-1096, 2013.
2. Roth M, Linkowski M, Tarim J, et al: Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer 120: 548-554, 2014.
3. Goguet-Surmenian E, Richard-Fiardo P, Guillemot E, et al: CXCR7-mediated progression of osteosarcoma in the lungs. Br J Cancer 109: 1579-1585, 2013.
4. Sun X, Cheng G, Hao M, et al: CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29: 709-722, 2010.
5. Hattermann K and Mentlein R: An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. Ann Anat 195: 103-110, 2013.
6. Singh AK, Arya RK, Trivedi AK, et al: Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Rev 24: 41-49, 2013.
7. i/o proteins in primary rodent astrocytes and human glioma cells. Glia 60: 372-381, 2012.
8. Yao X, Zhou L, Han S, et al: High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer. J Int Med Res 39: 1253-1264, 2011.
9. Hattermann K, Held-Feindt J, Lucius R, et al: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 70: 3299-3308, 2010.
10. Wang L, Chen W, Gao L, et al: High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. World J Surg Oncol 10: 212, 2012.
11. Gebauer F, Tachezy M, Effenberger K, et al: Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma. J Surg Oncol 104: 140-145, 2011.
12. Schrevel M, Karim R, ter Haar NT, et al: CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. Br J Cancer 106: 1520-1525, 2012.
13. Heinrich EL, Lee W, Lu J, et al: Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med 10: 68, 2012.
14. Gosalbez M, Hupe MC, Lokeshwar SD, et al: Differential expression of stroma derived factor-1 isoforms in bladder cancer. J Urol: Nov 26, 2013 (Epub ahead of print). doi: 10.1016/j.juro.2013.11.053.
15. Liu Z, Sun DX, Teng XY, et al: Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma. Endocr Pathol 23: 247-253, 2012.
16. + progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. Eur J Haematol 85: 472-483, 2010.
17. Hao M, Zheng J, Hou K, et al: Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol 84: 204-214, 2012.
18. Guo JC, Li J, Yang YC, et al: Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats. PLoS One 8: e82910, 2013.
19. Monnier J, Boissan M, L'Helgoualc'h A, et al: CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer 48: 138-148, 2012.
20. Hattermann K, Mentlein R and Held-Feindt J: CXCL12 mediates apoptosis resistance in rat C6 glioma cells. Oncol Rep 27: 1348-1352, 2012.
21. Xue TC, Han D, Chen RX, et al: High expression of CXCR7 combined with alpha fetoprotein in hepatocellular carcinoma correlates with extra-hepatic metastasis to lung after hepatectomy Asian Pac J Cancer Prev 12: 657-663, 2011.
22. Gahan JC, Gosalbez M, Yates T, et al: Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis. J Urol 187: 827-833, 2012.
23. Guillemot E, Karimdjee-Soilihi B, Pradelli E, et al: CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver. Br J Cancer 107: 1944-1949, 2012.
24. Tang T, Xia QJ, Chen JB, et al: Expression of the CXCL12/SDF-1 chemokine receptor CXCR7 in human brain tumours. Asian Pac J Cancer Prev 13: 5281-5286, 2012.
25. Zabel BA, Lewén S, Berahovich RD, et al: The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol Cancer 10: 73, 2011.
26. Zheng K, Li HY, Su XL, et al: Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 29: 31, 2010.
27. Décaillot FM, Kazmi MA, Lin Y, et al: CXCR7/CXCR4 heterodimer constitutively recruits β-arrestin to enhance cell migration. J Biol Chem 286: 32188-32197, 2011.
28. Liu FY, Zhao ZJ, Li P, et al: NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 25: 383-391, 2011.
29. Yates TJ, Knapp J, Gosalbez M, et al: C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer. Cancer 119: 61-71, 2013.
30. Risio M: Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers. J Cell Biochem (Suppl) 16G: 79-87, 1992.
31. Hornebeck W, Lambert E, Petitfrère E and Bernard P: Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 87: 377-383, 2005. (Pubitemid 40387617)
32. Dong S, Kong J, Kong F, et al: Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. J Transl Med 11: 273, 2013.